Susquehanna International Group, LLP I Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $18,308 - $12.7 Million	-79,600 Reduced 43.98%	101,400 $17,000
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $10,741 - $21,482	-46,700 Reduced 20.51%	181,000 $47,000
Q1 2022 May 16, 2022	BUY	$0.3 - $0.61 $21,090 - $42,883	70,300 Added 44.66%	227,700 $98,000
Q4 2021 Feb 14, 2022	SELL	$0.55 - $1.04 $99,165 - $187,512	-180,300 Reduced 53.39%	157,400 $87,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $361,460 - $518,320	-341,000 Reduced 50.24%	337,700 $358,000
Q2 2021 Aug 11, 2021	BUY	$1.22 - $1.65 $10,126 - $13,695	8,300 Added 1.24%	678,700 $1.03 Million
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $590,472 - $1.31 Million	500,400 Added 294.35%	670,400 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $119,805 - $255,584	114,100 Added 204.11%	170,000 $179,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $6.41 $95,030 - $358,319	55,900 New	55,900 $113,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.